Bausch Health Companies Inc. (NYSE:BHC) Is Favoured by Institutional Owners Who Hold 56% of the Company
Bausch Health Put Volume Heavy and Directionally Bearish
Bausch (BHC) Upgraded to Buy: Here's What You Should Know
Bausch Health Announces CABTREO Receives Positive Reimbursement Recommendations
PrCABTREOTM (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide Gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations From Canada's Drug Agency and Quebec's INESSS
Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis
